A detailed history of Baker Boyer National Bank transactions in Johnson & Johnson stock. As of the latest transaction made, Baker Boyer National Bank holds 8,540 shares of JNJ stock, worth $1.42 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
8,540
Previous 10,124 15.65%
Holding current value
$1.42 Million
Previous $1.6 Million 22.05%
% of portfolio
0.44%
Previous 0.55%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$144.38 - $157.78 $228,697 - $249,923
-1,584 Reduced 15.65%
8,540 $1.25 Million
Q1 2024

Apr 12, 2024

SELL
$155.22 - $162.74 $40,357 - $42,312
-260 Reduced 2.5%
10,124 $1.6 Million
Q4 2023

Jan 12, 2024

SELL
$145.6 - $158.88 $25,188 - $27,486
-173 Reduced 1.64%
10,384 $1.63 Million
Q3 2023

Oct 12, 2023

BUY
$155.75 - $174.48 $327,853 - $367,280
2,105 Added 24.91%
10,557 $1.64 Million
Q2 2023

Jul 11, 2023

SELL
$154.35 - $166.11 $49,855 - $53,653
-323 Reduced 3.68%
8,452 $1.4 Million
Q1 2023

Apr 17, 2023

BUY
$151.05 - $180.26 $25,225 - $30,103
167 Added 1.94%
8,775 $1.36 Million
Q4 2022

Jan 20, 2023

SELL
$160.2 - $179.79 $125,436 - $140,775
-783 Reduced 8.34%
8,608 $0
Q2 2022

Jul 08, 2022

SELL
$168.19 - $186.01 $67,780 - $74,962
-403 Reduced 4.11%
9,391 $1.67 Million
Q1 2022

Apr 15, 2022

SELL
$158.14 - $179.59 $20,400 - $23,167
-129 Reduced 1.3%
9,794 $1.74 Million
Q4 2021

Jan 24, 2022

BUY
$155.93 - $173.01 $82,954 - $92,041
532 Added 5.66%
9,923 $1.7 Million
Q2 2021

Jul 07, 2022

BUY
$159.48 - $171.07 $217,211 - $232,997
1,362 Added 16.96%
9,391 $1.67 Million
Q1 2018

Apr 19, 2018

SELL
$125.1 - $148.14 $184,522 - $218,506
-1,475 Reduced 15.52%
8,029 $1.03 Million
Q4 2017

Jan 19, 2018

BUY
$131.22 - $143.62 $4,592 - $5,026
35 Added 0.37%
9,504 $1.33 Million
Q3 2017

Oct 16, 2017

BUY
$129.47 - $135.38 $1.23 Million - $1.28 Million
9,469
9,469 $1.23 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Baker Boyer National Bank Portfolio

Follow Baker Boyer National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Boyer National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Baker Boyer National Bank with notifications on news.